Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient
1 Immunology Department, Beaumont Hospital, Dublin 9, Ireland
2 Department of Renal Medicine, Beaumont Hospital, Dublin 9, Ireland
3 Microbiology Department, Beaumont Hospital, Dublin, Ireland
4 Health Protection Surveillance Centre, Dublin, Ireland
World Allergy Organization Journal 2013, 6:16 doi:10.1186/1939-4551-6-16Published: 30 September 2013
The prevalence of Clostridium difficile infection (CDI) is increasing worldwide. Oral vancomycin is an effective and frequently used treatment. However, patients with CDI who are allergic to intravenous vancomycin cannot receive oral vancomycin due to the risk of anaphylaxis if given the oral form.
We present a case where oral vancomycin desensitisation was used to successfully treat a vancomycin allergic patient with recurrent CDI.